Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA grants orphan status to Dusa drug
Esophageal dysplasia occurs in some patients with Barrett’s esophagus, a leading cause of esophageal cancer. The incidence of esophageal cancer is one of the most rapidly growing in
Esophageal dysplasia occurs in some patients with Barrett’s esophagus, a leading cause of esophageal cancer. The incidence of esophageal cancer is one of the most rapidly growing in
Patients participating in the study will receive 52 weeks of treatment and will undergo safety and efficacy assessments using primary criterion of gadolinium-enhancing lesions and secondary criterion of
<p>Shareholder Chris Larson, of San Diego, has filed the suit in Montgomery County's circuit court in Maryland in an attempt to block the deal and force the board
<p>Under the terms of the agreement, biopharmaceutical company Medarex and Organon plan to share development and commercialization responsibilities on any antibody-based therapeutics resulting from this collaboration, and to
The FDA’s vaccines and related biological products advisory committee (VRBPAC) voted that the data collected demonstrates the efficacy of FluMist in children between six and 59 months of
Rocgel will be distributed in France and in French-speaking African countries, BioProgress said. The product is currently prescription-only but has the potential, and registration approvals, for sales into
“It is believed that a low fat diet can improve the cholesterol lowering effect of statin therapy in dyslipidemic patients. We believe that OBE101’s anti-fat craving effect may
The trial, which is being conducted following the successful filing of an investigational new drug application with the FDA, is designed as a single-center, randomized, open-label, sequential cohort
InterMune said that it would be running two phase III trials, designed to evaluate the safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis (IPF) patients with mild
Tests based on biomarker research could have a profound impact on the management of MS by increasing the ability of physicians to measure their patient’s level of disease